The FDA plans to mine data submitted by patients on the site PatientsLikeMe.
The FDA, in an attempt to gather post-marketing data directly from the source, is planning to access data submitted on the patient-networking website PatientsLikeMe. The hope is to collect data that patients submit on drug-use experiences, symptoms, and hospitalizations.
The project is currently in its exploratory phase. “We’re hoping we can find information on the impact of adverse events on patients’ day-to-day lives,” said Gerald Dal Pan, director of the Office of Surveillance and Epidemiology at the FDA, in a statement.
Read more on Bloomberg News: http://bloom.bg/1Laqub8
Higher Weight-Adjusted Waist Index Tied to Greater Mortality Risk in Patients With Osteoarthritis
April 23rd 2025Researchers consider the weight-adjusted waist index a more precise predictor of mortality risk in patients with osteoarthritis than traditional obesity measures, like body mass index.
Read More